-
Volition's Nu.Q® Provides Accurate, Non-Invasive Testing For Cancer Diagnosis In Humans And Canines
Monday, April 5, 2021 - 1:49pm | 903Read More...The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Cancer is the 2nd-leading cause of death in humans, responsible for 1 out of 6 deaths worldwide every year. Currently, there are 18.1...
-
Volition Has Released A Screening Test To Help Detect Early Stages Of Cancer In Dogs
Friday, December 4, 2020 - 10:30am | 601Read More...The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Given the growing population, it is expected that the number of cancer diagnoses will continue to increase. Currently, cancer is the...



